SIPNOSE
SipNose develops an innovative nasal delivery device for local, systemic, and central nervous system indications. The company's flexible solution is suitable for clinical or home use, for daily or emergency administration, for pediatric, adult, and geriatric patients. The company's devices allows new treatments for a wide variety of neurological disorders. Founded in 2011, SipNose collaborates with worldwide pharmaceutical and biopharmaceutical companies. It is headquartered in Yoqne`am `illit, Israel.
SIPNOSE
Industry:
Biopharma Biotechnology Health Care Medical Device Pharmaceutical
Founded:
2011-10-01
Address:
Yoqne`am `illit, HaZafon, Israel
Country:
Israel
Website Url:
http://www.sipnose.com
Status:
Active
Contact:
+972-4-8200881
Email Addresses:
[email protected]
Technology used in webpage:
Google Apps For Business Comodo SSL
Similar Organizations
Biodesign Innovation Labs
Biodesign Innovation Labs builds life-support systems for patients.
Current Employees Featured
Founder
Official Site Inspections
http://www.sipnose.com
- Host name: israel54.jetserver.net
- IP address: 81.218.83.100
- Location: Jerusalem Israel
- Latitude: 31.7808
- Longitude: 35.2287
- Timezone: Asia/Jerusalem
More informations about "SipNose"
sipnose – sipnose.com
SipNose’s internal pipeline includes drug-device combination products, pursuing 505(b)(2) approval pathway; Technology and Applications. SipNose’s intranasal drug delivery platform uses an innovative mechanism that improves efficacy, …See details»
SipNose - Crunchbase Company Profile & Funding
SipNose develops an innovative nasal delivery device for local, systemic, and central nervous system indications. The company's flexible solution is suitable for clinical or home use, for …See details»
About - SipNose
Dr. Shichor brings to SipNose her extensive experience in leading research and development programs and managing product development projects from concept to product.Dr. Shichor …See details»
SipNose Company Profile 2024: Valuation, Investors, Acquisition
SipNose General Information Description. Developer of intranasal drug delivery devices designed to improve drug efficacy, patient compliance, and safety through non-invasive nose-to-brain …See details»
Sipnose Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
SipNose is a novel non-invasive intranasal direct nose-to-brain drug delivery platform that delivers drugs to the central nervous system consistently and rapidly. Herein, we study a SipNose …See details»
SipNose - Products, Competitors, Financials, Employees, …
SipNose specializes in intranasal drug delivery technology within the pharmaceutical industry. The company offers devices that facilitate non-invasive medication administration directly to the …See details»
SipNose - Overview, News & Similar companies | ZoomInfo.com
Jun 1, 2021 Based in Israel, SipNose is a clinical stage nasal delivery company that has developed an innovative Cribriform Targeted Device for non-invasive de livery of …See details»
Aptar Pharma acquires SipNose - 2024-10-09 - Crunchbase
Oct 9, 2024 Acquired Organization: SipNose SipNose develops an innovative nasal delivery device for local, systemic, and central nervous system indications. Acquiring Organization: …See details»
Aptar Pharma Acquires Device Technology Assets of SipNose to …
Oct 9, 2024 SipNose’s expanded innovative delivery systems, which include liquid and dry powder intranasal delivery, will further strengthen Aptar Pharma’s nose-to-brain pathway …See details»
SipNose - VentureRadar
SipNose collaborates with global pharmaceutical companies and offers a variety of reusable or disposable devices suitable for clinical and home use, ranging from pediatric to geriatric …See details»
SipNose - Company Profile - Tracxn
Nov 27, 2024 SipNose is focussed on developing a nasal delivery device which is suitable for medical applications from nose to brain. Its flagship product is a noninvasive and patent …See details»
Aptar Pharma Acquires Device Technology Assets of SipNose
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announces that it has acquired all device technology assets from the …See details»
SipNose - Israeli Startup | Startup Nation Finder
Jun 1, 2021 SipNose focuses on nose-to-brain medical applications and is developing a nasal delivery platform for local, systemic, and central nervous system indications. The company’s …See details»
SipNose - Providing a Breakthrough in Neurology
Jul 25, 2024 SipNose’ first clinical proof of concept study, which was in anti-epileptic seizures was the first success in this sense. “I remember how excited we were, that not only we got the …See details»
Technology - SipNose
SipNose collaborates with world leading professionals with proven track records in the fields of biomedical product development and commercialization for. Enabling technology for novel …See details»
SipNose - Contacts, Employees, Board Members, Advisors & Alumni
Organization. SipNose . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. SipNose has 2 current …See details»
Intranasal Therapy for Treatment and Prevention – sipnose
SipNose is seeking to collaborate with companies who have effective drugs or formulations, and which joined the effort to cope with the worldwide coronavirus pandemic. SipNose proposes a …See details»
PRODUCTS – sipnose
SipNose’s intranasal drug delivery platform use an innovative mechanism that improves efficacy, patient compliance and safety. SipNose offers variety of devices that are designed and …See details»
NEWS – sipnose
Jun 19, 2019 2021. Dr. Iris Shichor recognized on Technology-Innovators' top 50 Healthcare Technology CEOs of 2021, June 2021See details»
“Direct Delivery of Medications from the Upper Nasal Cavity
“The SipNose technology may assist in the field of psychiatry where the need for drugs delivery to the brain is obvious. This is a field where no significant breakthrough has occurred for many …See details»